Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease. [electronic resource]
Producer: 20190107Description: 7264-7270 p. digitalISSN:- 1643-3750
- C-Reactive Protein -- metabolism
- Child, Preschool
- Drug Therapy, Combination
- Female
- Humans
- Immunoglobulins, Intravenous -- administration & dosage
- Infant
- Infliximab -- administration & dosage
- Leukocyte Count
- Male
- Mucocutaneous Lymph Node Syndrome -- blood
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.